Nephrogenic Gadolinium Biodistribution and Skin Cellularity Following a Single Injection of Omniscan in the Rat
- 1 September 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 45 (9), 507-512
- https://doi.org/10.1097/rli.0b013e3181eb51f2
Abstract
Objectives: The development of nephrogenic systemic fibrosis (NSF) following MRI contrast examination has been associated with gadolinium (Gd) toxicity. Animal models should show the key features of NSF in man where, the only immutable epidemiological feature is renal impairment. A rat model of chronic renal insufficiency has been employed to establish whether tissue gadolinium retention and increased skin cellularity following a gadolinium based contrast agent (GBCA) can be correlated with a reduction in renal function. The GBCA chosen for investigation was Omniscan, the least stable of the commercially available agents. Materials and Methods: Wistar rats were subjected to 5/6 subtotal nephrectomy (SNx) under isoflurane anesthesia. The glomerular filtration rate (GFR) was assessed from serum creatinine and creatinine clearance. Two SNx rats groups were established, following either 75% or 80% resection of the kidney, which reduced the GFR down to 40% and down to 20%, respectively, of sham-operated controls. Three months after surgery, rats received a single intravenous injection of either saline or Omniscan (gadodiamide 2.5 mmol/kg). Four weeks later, the Gd content of serum, skin, liver, and bone was measured by inductively coupled plasma mass spectrometry and skin cellularity determined. Results: In sham-operated rats, Gd was detected in skin < liver < bone. SNx rats with the GFR reduced down to 20% normal, had an increased tissue Gd concentration in bone (2.5-fold), skin (3-fold), and liver (10-fold) compared with sham-operated controls. The Gd concentration in all 3 tissues showed a positive linear correlation with serum creatinine (P < 0.01). No external skin lesions were observed. The skin cellularity of rats with the GFR reduced down to 20% of normal was increased following Omniscan, together with positive immunostain for CD34 and prolyl-4-hydroxylase. Conclusions: The SNx rat is a sensitive model for investigating the pathophysiology of NSF. A positive linear correlation was obtained between tissue Gd and serum creatinine, the major clinical marker of renal function. An increase in skin cellularity, a feature of human NSF, was demonstrated in rats with a level of renal impairment equivalent of stage 4 chronic kidney disease following just a single intravenous dose of Omniscan. This response was obtained in the absence of ulcerogenic skin lesions, at skin Gd concentrations as low as 50 nmol/g.Keywords
This publication has 18 references indexed in Scilit:
- Effects of gadolinium contrast agents in naïve and nephrectomized rats: Relevance to nephrogenic systemic fibrosisActa Radiologica, 2009
- Current Status of Gadolinium Toxicity in Patients with Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- A Preclinical Study to Investigate the Development of Nephrogenic Systemic Fibrosis: A Possible Role for Gadolinium-Based Contrast MediaInvestigative Radiology, 2008
- Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be ConcernedAmerican Journal of Roentgenology, 2007
- Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition?The British Journal of Radiology, 2007
- Nephrogenic Systemic Fibrosis: A Review and Exploration of the Role of GadoliniumAdvances in Dermatology, 2007
- Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a reviewFundamental & Clinical Pharmacology, 2006
- Gadolinium determination in tissue samples by inductively coupled plasma mass spectrometry and inductively coupled plasma atomic emission spectrometry in evaluation of the action of magnetic resonance imaging contrast agentsThe Analyst, 1998
- Biodistribution of Radiolabeled, Formulated Gadopentetate, Gadoteridol, Gadoterate, and Gadodiamide in Mice and RatsInvestigative Radiology, 1995
- Analytical Reviews in Clinical Biochemistry: The Estimation of CreatinineAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1986